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Antibody-dependent enhancement (ADE), a phenomenon in which
viral replication is increased rather than decreased by immune sera,
has been observed in vitro for a large number of viruses of public
health importance, including flaviviruses, coronaviruses, and ret-
roviruses. The most striking in vivo example of ADE in humans is
dengue hemorrhagic fever, a disease in which ADE is thought to
increase the severity of clinical manifestations of dengue virus
infection by increasing virus replication. We examine the epide-
miological impact of ADE on the prevalence and persistence of viral
serotypes. Using a dynamical system model of n cocirculating
dengue serotypes, we find that ADE may provide a competitive
advantage to those serotypes that undergo enhancement com-
pared with those that do not, and that this advantage increases
with increasing numbers of cocirculating serotypes. Paradoxically,
there are limits to the selective advantage provided by increasing
levels of ADE, because greater levels of enhancement induce large
amplitude oscillations in incidence of all dengue virus infections,
threatening the persistence of both the enhanced and nonen-
hanced serotypes. Although the models presented here are spe-
cifically designed for dengue, our results are applicable to any
epidemiological system in which partial immunity increases patho-
gen replication rates. Our results suggest that enhancement is
most advantageous in settings where multiple serotypes circulate
and where a large host population is available to support pathogen
persistence during the deep troughs of ADE-induced large ampli-
tude oscillations of virus replication.
dengue  adaptive  trade-off
An estimated 50–100 million people are afflicted by denguefever each year (1). Two to five hundred thousand of these
cases occur as the severe, life-threatening form of the disease,
dengue hemorrhagic fever (DHF) (2). The factors that lead to
severe disease are debated, with both viral factors and host
immune status thought to contribute (3). Evidence shows that
preexisting heterotypic immunity is a strong risk factor for the
development of DHF (4–6). Several nonmutually exclusive
mechanisms have been proposed to explain how sequential
dengue infections might cause severe disease, including abnor-
mal T cell activation and cytokine release or apoptosis (7, 8).
However, the leading hypothesis is that DHF is associated with
a phenomenon called antibody-dependent enhancement (ADE)
of dengue virus replication. A non-neutralizing antibody from
previous heterotypic dengue infection has been shown to en-
hance the growth of virus in vitro (9) and in vivo in nonhuman
primates (10). Additionally, the presence of transplacentally
acquired maternal dengue antibodies has been associated with
DHF in infants (4). Higher viremia has been observed in
individuals experiencing their second dengue infection than
those undergoing primary infection, although one other study
was inconclusive (11, 12). There is also evidence that viral strains
vary in virulence (13). It is most likely that both viral factors and
immune status are important in determining the severity of
disease. Epidemics in the Americas demonstrate that both viral
factors and host immune states play clear roles in disease
severity. Secondary infections of dengue serotype 2 have been
associated with severe disease in several settings in the Americas,
but only for viruses of Southeast Asian origin, not those of
American origin (14–16). Because ADE appears to be a char-
acteristic of some dengue viruses and not others, the present
work seeks to explore the particular dynamic mechanisms and
settings that make ADE an advantageous strategy.
Although the model we present is specific to dengue, the
results are applicable to any microbial agent affected by immune
enhancement. ADE has been observed in vitro for other families
of pathogens, including retroviruses and coronaviruses (17–19).
Accordingly, ADE is a concern in the development of vaccines
against HIV and severe acute respiratory syndrome as well as
dengue (17, 20).
ADE of dengue viruses was first observed in Southeast Asia
(21), and all four serotypes of dengue have circulated in South-
east Asia for at least 50 years (22). The association of DHF with
secondary infection and ADE has been observed in Southeast
Asia for many years as well (21). We hypothesize that the large
urban centers of Southeast Asia where multiple serotypes of
dengue circulate at high levels of transmission provide the most
advantageous environment for the emergence of ADE. In a
previous study, we observed spatial-temporal traveling waves in
the incidence of DHF that emanated from Bangkok and spread
radially throughout the country (23). In that work, we hypoth-
esized that Bangkok acts as a pacemaker for the surrounding
region because all four serotypes are maintained there, provid-
ing a source of periodic reintroductions of particular serotypes
to the surrounding region. In this study, we take steps toward
addressing these hypotheses by studying the dynamics of dengue
circulation in a single population. We develop a model of the
dynamics of dengue transmission in the presence of ADE. We
model the cocirculation of four serotypes as occurs in nature and,
more generally, n serotypes to study the effect of ADE in systems
of varying numbers of cocirculating serotypes. We use this model
to determine the impact of ADE on competition between
serotypes and on the persistence of multiple serotypes in a single
population.
We speculate that ADE confers a fitness advantage on en-
hanced viruses, and that there is ongoing natural selection for
such strains. We hold that it will be important to disease control
efforts to understand the processes, such as ADE, that affect the
evolution and pathogenicity of dengue viruses. Although new
serotypes have been reported prematurely in the literature (24),
no new serotypes beyond the four known have emerged. We
explore the consequences of emergence of new dengue serotypes
by comparing the dynamics of model systems with two to six
serotypes.
Mathematical models describing the transmission of dengue
viruses appeared in the literature as early as 1970 (25). Models
have focused on several different aspects of transmission; sim-
Abbreviations: ADE, antibody-dependent enhancement; DHF, dengue hemorrhagic fever.
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ulating the abundance of the mosquito vector and its effect upon
transmission (26), the effect of ADE on transmission dynamics
(27), and the effect of seasonality on transmission dynamics (28).
Research groups have explored the effects of ADE on the
dynamics of dengue transmission by using several different
approaches (25, 27, 29, 30). Feng (29) examined the effect of
ADE in a two-serotype model via the inclusion of a parameter
that increased the susceptibility of those individuals who had
previously been exposed to one serotype. Kawaguchi (30)
examined the impact of increased mortality of secondary
dengue infections upon competition and coexistence of two
serotypes. Ferguson et al. (27) used a slightly different ap-
proach to examine the effect of ADE on the dynamics of
dengue transmission in a two-serotype model. In their com-
partmental model, the authors assume that ADE increases the
viral load of those individuals experiencing a second, hetero-
typic infection (27). Thus, secondary infections act to increase
the force of infection (the per capita rate of infection) of the
second infecting serotype. Evidence that ADE acts to increase
viral loads of those undergoing secondary infection (11)
suggests that this formulation more accurately ref lects the
biology of dengue infection than the formulation by Feng (29).
Because individuals experiencing a secondary infection have
higher viral loads, there is a higher probability that a blood
meal taken by a mosquito from such an individual would have
sufficient levels of virus to pass infection on to another
individual. This observation, that secondary infections in-
crease viral loads, directly supports a theory that preexisting
immunity increases the transmissibility of secondary infec-
tions. In contrast, to date, there is no clinical or epidemiolog-
ical evidence that preexisting heterotypic immunity increases
susceptibility to infection.
Materials and Methods
Our model is based on the standard Susceptible, Infectious, and
Recovered epidemiologic model. The model builds on previous
work that has addressed the interaction of multiple serotypes of
a disease within a population (31, 32). We have generalized the
two-serotype dengue model developed by Ferguson et al. (27) to
n dengue serotypes (n  2 to 6). The dynamics of n serotypes
circulating in a single population of constant size are given by
dXt
dt
   Xt 
i
 Yi t   i
ji
Yji t   X t, [1]
dYi t
dt
 X t  Yi t   i
ji
Yji t   Yi t  Yi t,
[2]
dZit
dt
 Yit Zit
ji
Yjt j
kj
Ykjt  Zit,
[3]
dYijt
dt
 ZitYjt j
kj
Ykjt  Yijt Yijt, [4]
dZt
dt
 
i, j,ij
Yijt Zt. [5]
(Note: All summations are from 1 to n, subject to restrictions
below the summation symbol.) X(t) is the fraction of the
population susceptible to all n serotypes, Yi(t) is the fraction
currently infectious with serotype i, Zi(t) is the fraction recov-
ered from infection with serotype i, Yij(t) is the fraction currently
infectious with serotype j having previously been infected by
serotype i, and Z(t) is the fraction that has recovered from two
infections of dengue. Individuals are assumed to be immune to
all serotypes of dengue after two sequential infections because
tertiary infections are reported very rarely (22). The total
number of compartments for a system of n serotypes is given by
n2  n  2. We assume that primary infection with any single
dengue serotype confers lifelong homotypic immunity but no
immunity to other serotypes. ADE is assumed to increase the
transmissibility of secondary infections of serotype i by a factor
labeled the ADE factor, i. For model simplicity, the transmis-
sion coefficient, , is assumed to be equal for each serotype. The
base value for the transmission coefficient was derived from
estimates of the basic reproductive rate, R0, for dengue in
Thailand (33). The force of infection for serotype i, the per capita
rate of acquisition of infection, is assumed to be proportional to
the total fraction infectious with serotype i but with the second-
ary infections weighted by the enhancement factor, i (27). An
ADE factor of 1 corresponds to no enhancement, whereas an
ADE factor of 2 means that secondary infections contribute
twice as much as primary infections to the force of infection. The
values of parameters in the model and the references used
appear in Table 1. For model simplicity, we assume that the
population is constant with a birth rate, , exactly equal to the
death rate. We assume that mortality rates in our population are
independent of disease status. We believe this assumption is a
reasonable because of the low case fatality rate of DHF (0.01)
and the much lower fatality rate of dengue infection (0.0001)
in Thailand (34). The work of Kawaguchi and Rohani (30, 35)
suggests that the dynamics of dengue are significantly impacted
by dengue-induced mortality only at much higher levels of
mortality than are observed. The rate of recovery, given by , is
assumed to be equal for primary and secondary infections. The
ADE factor is varied in our model runs from 1 to 5.
Results
Introduction of an Enhanced Strain. We have chosen to represent
ADE as a characteristic of an entire serotype for most of the
model results presented below rather than allowing the ADE
factor to vary among strains within a serotype. Although this
assumption simplifies the model results, it is more probable that
ADE would emerge in a particular viral strain within a serotype.
We hypothesize that if ADE were to emerge as a characteristic
of one viral strain, it would competitively displace all other viral
strains within a serotype. To address this hypothesis, we adapted
the modeling framework described above to simulate multiple
viral strains within one serotype. For simplicity, we constructed
a model of two serotypes, one serotype consisting of just one
viral strain and the other serotype consisting of two viral strains.
The two strains within a serotype conferred perfect immunity to
each other upon infection. The two strains differed only in the
degree of ADE they underwent, one having an ADE factor of 1,
the other an ADE factor of 2. In this model, we have confirmed
that the enhanced strain competitively displaces the nonen-
hanced strain within its serotype. However, competition between
strains of diverse levels of enhancement and other viral charac-
teristics (e.g., transmissibility of nonenhanced infection) should
Table 1. Parameter values used in this model
Parameter Value Ref.
, transmission coefficient, year	1 400 33
, I/host life span, year	1 0.02 27
, recovery rate, year	1 100 27
i, ADE factor of serotype i 1–5 —
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be studied in the future. In this paper, we assume that each strain
within a serotype experiences an identical level of ADE.
General Description of Model Behavior. We determined the be-
havior of our systems while changing the ADE factor for all
serotypes at once (denoted all), and for changing the value of
the ADE factor for just one serotype (without loss of generality
choosing 1 to vary) while holding the ADE factor equal to 1
for all other serotypes. At different values of all and 1, the
behavior of the solutions changes dramatically. Fig. 1 presents
example time series of the simulations for different values of
all in a four-serotype model. Shown in the solution time series
are the total infectious fractions for each of the four serotypes.
These solutions exhibit fixed point behavior (where each
disease state settles to a constant fraction of the population)
(A), stable oscillations (B), synchronized, unstable oscillations
with interspersed chaotic desynchronization (C), synchronized
pairs of serotypes that exhibit a nonzero phase angle with
respect to one another (D), and completely desynchronized,
chaotic behavior (E). Note that although we have assumed
equal base transmission rates for each of the serotypes, the
prevalence of each serotype is not equal at all times. A general
trend in these results is for increasingly large oscillations with
increasing enhancement.
We present a more complete characterization of the behavior
of these systems as all is varied in Fig. 2. Fig. 2 presents a
bifurcation diagram showing the behavior of the susceptible
fraction in the four-serotype system as all is changed. Plotted in
the figure are the local minima of the susceptible fraction of the
population over 100 years of simulations for 20 separate random
initial conditions at varying levels of all. Steady-state solutions
are represented by a single point. Oscillatory solutions are
represented by a single point only if the same local minimum is
reached in each cycle. Points on the horizontal axis for which
there are multiple points on the vertical axis indicate values of
all for which multiple local minima occur over the 100-year
interval. Simulations in which the ADE factor is varied for just
one serotype, with the remaining serotypes having ADE fixed at
1 (data not shown) and the data above show there is a trend for
oscillations to have increasing amplitude as either all or 1
increases.
Selective Advantage of ADE. It is intuitively appealing to viewADE
as an adaptive strategy for viruses that grants increased trans-
missibility in the presence of high levels of population immunity.
We quantitatively measure the effect of ADE on the prevalence
of a serotype undergoing enhancement by comparing the sero-
type’s equilibrium prevalence at various levels of enhancement
in a system of n circulating serotypes. Fig. 3 presents the
equilibrium prevalence of serotype 1 (serotype 1 is arbitrarily
chosen as the enhanced serotype) at levels of 1 varying from 1
(no enhancement) to 2 in settings of 2, 3, 4, 5, and 6 cocirculating
serotypes. We set i  1 for i  1. Then we consider the effect
of serotype 1 gaining ADE. For large values of 1, the solutions
oscillate (discussed in subsequent sections). However, for rea-
sonably small changes in 1 (1 
 2), the equilibrium point is
stable. As expected, we find that the equilibrium prevalence of
serotype 1 increases as 1 increases. During the initial increase
in stable equilibria, the slope of the increase depends on the
number of cocirculating serotypes. For every unit increase in 1,
the increase in prevalence that occurs is greater in systems with
greater numbers of cocirculating serotypes (Fig. 3). Solving for
the equilibrium point of Eqs. 1–5, we performed an asymptotic
expansion for the primary infectives of serotype 1 when 1 
1   and i  1 for i  1, where  is a small parameter and the
mortality terms of Eqs. 1–5 were omitted for simplicity. As a
function of the number of serotypes, the fraction of the popu-
lation with primary infection of serotype 1 is
Fig. 1. Example time series from simulation with i equal for all i. (A) all 
1.5. (B) all  1.88. (C) all  2.1. (D) all  2.7. (E) all  3.2. Log (base 10) axes
are used for the vertical axes. The horizontal axis is time in years for each of the
plots. Four series are shown in each plot displaying the total infectious
compartments for each serotype colored red, green, blue, and black (all four
compartments are identical in A and B). A threshold value of 1 10	8 used to
define extinction in Fig. 5 is indicated by the dotted horizontal line (data not
shown in A).
Fig. 2. Behavior of the susceptible fraction of the dengue four-serotype
model for various values of all, the ADE factor for each serotype. Shown are
the local minima of the susceptible fraction (log base 10) occurring over 100
years for 20 runs at each setting of all. The first 5,000 years of numerical
integrations were discarded to avoid transient behavior before recording
local minima for 100 years. The location of the Hopf bifurcation is indicated by
the red arrow.
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The slope of this fraction as a function of  increases as n
increases. Thus, we find that ADE has more impact when there
are more serotypes circulating, because of the larger pool of
individuals who have been exposed to one heterotypic serotype.
Similarly, we find that the impact of ADE is greater in systems
in which the force of infection of the nonenhanced serotypes was
higher (data not shown), another factor that increases the
proportion of individuals who have experienced infection by one
heterotypic serotype.
Onset of Oscillations. Ferguson et al. (27) demonstrated that the
inclusion of ADE in models of two dengue serotypes induces
cycles in incidence. We also find oscillations in incidence in each
of the n serotype models. As the ADE factor increases, these
models undergo a Hopf bifurcation. At this point (indicated by
the red arrow in Fig. 2) the behavior of the equilibrium solutions
of these models changes from steady states to limit cycles. The
point at which these systems undergo the bifurcation in i varies
as a function of the number of serotypes. In our models in which
the ADE factor is equal for all serotypes, we find that the value
of all at which oscillations begin declines from 2.7 for systems
of only two serotypes to 1.7 for a system of six serotypes. The
Hopf branch for each of the n serotype systems begins with
oscillations of period 3 years. Interestingly, the period of the
oscillations at the onset does not vary significantly with the
number of serotypes. Also, these Hopf branches are stable for
only a small range of all to the right of the bifurcation point.
Another bifurcation leads to chaos-like oscillations as indicated
by the Lyapunov exponents (41).
Threats of ADE to Persistence. As the ADE factor increases, the
oscillations that these systems experience increase in amplitude.
As these oscillations increase in amplitude, the minimum prev-
alence of the dengue viruses in the troughs between epidemics
decreases. Oscillations with very low minima are assumed to
threaten persistence. Our continuous system of ordinary differ-
ential equations does not allow for fadeout. However, we
characterized the persistence of viruses in any given model
formulation by calculating the time interval for which the
prevalence of a particular dengue serotype was above a chosen
small fraction (1  10	8). This fraction was selected to be one
order of magnitude below the fraction corresponding to one
individual in a population the size of Bangkok (1  107). This
threshold is represented by the dashed lines in Fig. 1. Fig. 4
presents the proportion of the interval spent above this threshold
as a function of all. At each value of all, the mean and range
of 50 solutions is shown. The largest ranges occur when several
coexisting stable solutions exist. As a general trend, as all
increases, the proportion of the solutions above this threshold
decreases. There is, however, one region, from 2.6 to 2.7, where
increases in all result in increases in the proportion of the
interval spent above threshold. This region corresponds to a loss
of synchrony across all serotypes. Before all 2.6, the behavior
of solutions includes large regions of synchrony between the
incidence of each serotype interspersed with chaotic regions with
reduced synchrony (I.B.S., unpublished data). During the re-
gions of synchrony, the four serotypes exploit the susceptible
fraction at synchronized time points, driving the susceptible
component to a very low fraction. Our intuition is that this
reduction in the susceptible fraction results in deeper troughs in
the incidence of all four serotypes. After all  2.6, the system
experiences a reduction in overall synchrony among the four
serotypes, with only certain subsets of the serotypes (two or three
serotypes) synchronized for large time periods. A similar de-
crease in the proportion of solutions that lie above the threshold
of 1  10	8 is observed while increasing the ADE factor of just
one serotype in the four serotype system (data not shown).
We also addressed the robustness of our results to asymmetry
in the amount of enhancement experienced by each serotype.We
recalculated the proportion of time above the threshold shown
in Fig. 4 as a function of i  mean  i where mean indicates
a contribution to all i that is systematically varied as all is in
Fig. 4. These results are shown in Fig. 5. Unlike Fig. 4, here the
i vary because of the contribution of i, a normal, random
variable with mean zero. Fig. 5 presents the mean and range of
the proportion above threshold as a function of mean where i
has a standard deviation of 0.1. The results of these runs are
qualitatively similar to the results where the ADE factor is
identical for all serotypes.
We find that the range of all  1 that does not induce
Fig. 3. Fraction primary infectious with serotype 1 in a system of 2–6
serotypes versus the ADE factor of serotype 1, 1, within range 1 to 2. In this
range of the ADE factor, each of the systems of n serotypes settles to a stable,
fixed point. Shown is the dependence of the steady-state value of the primary
infectious compartment of the enhanced serotype on 1. Results for each of
the n serotype systems are color-coded according to Inset.
Fig. 4. Persistence of dengue serotype 1 as a function of all. At each value
of all, the proportion of the simulated interval of 5,000 years above 1 10	8
is presented. The first 5,000 years of each model run were discarded to
minimize the effect of transient behaviors. Shown are means (circles) and
ranges of 50 simulations (from randomly perturbed initial conditions). The red
arrow indicates the location of the Hopf bifurcation. The letters A–E indicate
the settings of all used for the time series appearing in the corresponding
lettered part of Fig. 1.
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oscillations reduces as the number of cocirculating serotypes
increases. This result suggests that the range of all that does not
have significant regions of reduced persistence decreases with
increasing numbers of cocirculating serotypes. Characterization
of the persistence of dengue in these other n serotype systems
should be considered for future study.
The Effect of Including Stochastic Noise. We have developed a
stochastic formulation of our system to explore the effect of
randomness on our results. We add to each of our disease state
compartments a noise term that is proportional to the variable.
In Eqs. 1–5 above, we add a random noise vector, 	, multiplied
by the corresponding variables (i.e., for each variable Vi, we add
a term 	iVi to the equation for dVidt). This noise term repre-
sents continuous multiplicative white noise, because the vector
	 consists of normally distributed random variables with mean
zero. Using this system, we recalculated the persistence mea-
surements from Fig. 4 as we varied the standard deviation of the
noise from 0.001 to 0.02. Results are show in Fig. 6. Numerical
integration of the stochastic formulation of these models yields
qualitatively similar results to the deterministic formulation. For
small standard deviations, the general trend is that the propor-
tion above the threshold for a given all increases. This trend is
expected because the noise breaks the synchrony of the solutions,
avoiding the lowest fractions in the large oscillations. As the
standard deviation increases, the persistence curve smoothes to
a monotonic decrease of proportion above threshold vs. ADE.
Discussion
We have described an evolutionary tradeoff between the advan-
tage that ADE grants dengue viruses in the form of increased
transmissability and the disadvantages of ADE due to an in-
creased probability of extinction at high levels of enhancement.
Other researchers have described a similar tradeoff between
short-term reproductive rates and long-term persistence for
pathogens in general (36, 37). Those authors hypothesize that
high reproductive rates are advantageous for short-term com-
petition, but high transmission induces boom-bust cycles that
threaten persistence. These cycles reflect the classic dynamical
overshoot of pathogens overexhausting the pool of susceptibles
resulting in population crash (36). We have observed a similar
phenomenon. In the case of ADE, there is an additional resource
that may be overused: the pool of individuals susceptible to
secondary infections. Our results suggest that there is a dynamic
fitness landscape for dengue viruses by using enhancement. ADE
initially provides an advantage to viruses in a population with
substantial immunity. However, as enhancement provides sub-
stantial advantage, the enhanced strains overcompete with other
serotypes and exhaust the pool of individuals susceptible to
secondary infections. The loss of this resource causes large-
amplitude cycles for the enhanced serotype and eliminates the
advantage gained by ADE (because there are very few secondary
infections). We note that the onset of these oscillations occurs
very quickly with respect to changes in ADE. Because ADE is
incompletely understood, it is difficult to speculate on how
enhanced virus replication might evolve over time (i.e., contin-
uously in small increments or in discrete jumps). Regardless of
the exact mechanism, our results suggest that there are dynam-
ical limitations to the extent to which this strategy can be
exploited. Our results also indicate that there is an optimal level
of enhancement for dengue viruses, the highest level of enhance-
ment that does not induce large amplitude cycles (In our present
model, this value implies that secondary infections would not be
more than approximately two to three times as transmissible as
primary infections).
Phylogenetic analysis of dengue viruses in several locales
suggest that the viruses undergo repeated genetic bottlenecks
(38, 39). During these bottlenecks, diverse populations of dengue
viruses experience dramatic declines in population numbers.
After these bottlenecks, a much less diverse population of viruses
remains. Seasonal f luctuations of mosquito populations have
been suggested as a mechanism for these population bottlenecks
(39). The dynamic cycles our models exhibit offer an alternative
mechanism for these population bottlenecks.
We have generalized the work of previous researchers (27) to
address n serotypes of dengue (n  2–6), including the case of
four cocirculating serotypes observed in many regions of the
world, and have examined the effects of ADE on persistence of
dengue viruses. With the addition of serotypes to our model
systems (over the two addressed by previous research), the Hopf
bifurcation occurs at smaller ADE values. Following from
observations of our four-serotype system, we expect an earlier
onset of large-amplitude cycles in systems with more serotypes.
Thus, enhancement may provide a mechanism that limits the
Fig. 5. Persistence of dengue serotype 1 as a function ofmean. In these runs,
the ADE factor for each serotype isimean i where i is a normal random
variable with mean zero and standard deviation 0.1. At each value of mean,
the mean and range of the proportion of the simulated interval of 5,000 years
above 1  10	8 for 50 simulations is presented.
Fig. 6. Persistence of dengue serotype 1 in the four-serotype stochastic
model as a function of all. At each value of all, the mean of the proportion
of the simulated interval of 5,000 years above 1  10	8 for 50 simulations is
presented. The black symbols present the results with no noise included. The
colored symbols present the resultant behavior from including multiplicative
noise of various standard deviations (ranging from 0.001 of the population for
each compartment to 0.02).
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number of serotypes that can cocirculate in any particular
setting.
There are several limitations to the approach we have taken.
Although we have addressed the impact of stochasticity in our
models, we have not modeled the extinction process explicitly.
The behavior of a stochastic, discrete individual model of this
systemmay exhibit different behavior. Our future work will focus
on validating the observations we have made in a stochastic
system with discrete individuals and more carefully analyzing the
temporal progression of extinctions. We have not included costs
of enhancement or tradeoffs between having enhancement and
other traits affecting transmission or other characteristics. We
expect there to be biological tradeoffs that are not explicitly
modeled here. Additionally, for simplicity, we have not included
seasonality in our models nor short-term cross-immunity be-
tween serotypes (40).
The extent to which dengue virus replication is enhanced in
humans is not fully understood nor has it been carefully quan-
tified. We have shown here that the exact ADE value has
important implications for setting the prevalence and incidence
of serotypes and competition between serotypes. Because severe
disease (DHF) is associated with secondary infections, ADE,
and increased replication, epidemiological limits on virus sur-
vival may also serve as clinical limits to disease severity. These
results suggest that there should be renewed attention on
measuring immune enhancement of virus replication in vitro and
in vivo.
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